oligonucleotid
purchas
idtdna
code
sar
epitop
residu
sar
protein
asvvniqkeidrlnevaknln
anneal
ligat
modifi
vector
code
peptid
monom
core
particl
result
plasmid
transform
eschericia
coli
strain
plyss
express
cell
novagen
madison
wi
usa
bacteri
growth
done
luria
broth
medium
presenc
ampicillin
chloramphenicol
express
induc
mm
isopropyl
h
express
cell
harvest
centrifug
g
min
frozen
purif
done
denatur
condit
cell
pellet
thaw
ice
resuspend
lysi
buffer
compos
urea
mm
mm
tri
ph
lyse
sonic
cell
membran
remov
centrifug
min
g
supernat
incub
nickel
bead
qiagen
valencia
ca
usa
h
protein
contamin
wash
column
use
ph
gradient
first
wash
done
lysi
buffer
second
third
wash
ph
respect
buffer
contain
urea
mm
mm
sodium
citrat
mm
imidazol
elut
done
ph
urea
mm
mm
sodium
citrat
mm
imidazol
puriti
verifi
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
peptid
ident
confirm
mass
spectrometri
follow
purif
denatur
monomer
peptid
dialyz
refold
buffer
mm
tri
ph
mm
nacl
glycerol
contain
urea
follow
urea
urea
urea
urea
urea
refold
buffer
protein
filter
polyvinyliden
fluorid
membran
filter
dialysi
milipor
slvv
rs
millipor
billerica
usa
circular
dichroism
cd
experi
perform
appli
photophys
pi
star
spectrapolarimet
circular
dichroism
spectra
record
nm
mm
sodium
phosphat
ph
mm
nacl
glycerol
temperatur
denatur
profil
obtain
path
length
cell
mgml
protein
concentr
follow
chang
molar
ellipt
nm
temperatur
increas
rate
hydrodynam
diamet
obtain
malvern
zetas
nano
malvern
worcestershir
uk
equip
laser
measur
done
buffer
contain
mm
tri
ph
mm
nacl
glycerol
sampl
neg
stain
uranyl
acet
spi
peptid
concentr
mgml
electron
micrograph
taken
philip
em
philip
electron
optic
eindhoven
netherland
transmiss
electron
microscop
acceler
voltag
kv
micrograph
scan
dpi
sediment
veloc
analysi
conduct
rpm
g
use
interfer
optic
analyt
ultracentrifug
fullerton
ca
usa
doubl
sector
synthet
boundari
cell
equip
sapphir
window
use
match
sampl
refer
menisci
rotor
equilibr
vacuum
period
h
rotor
acceler
rpm
interfer
scan
acquir
interv
h
extinct
coeffici
molecular
mass
partial
specif
volum
solvent
densiti
calcul
use
sednterp
initi
analysi
perform
use
sedfit
obtain
c
distribut
dcdt
obtain
g
distribut
ten
balbc
mice
immun
interperiton
primari
immun
contain
sampl
mm
tri
ph
mm
nacl
glycerol
buffer
mgml
secondari
tertiari
one
booster
immun
day
also
contain
sampl
ph
buffer
mice
kill
bled
day
neg
control
nanoparticl
without
sar
epitop
use
immun
five
mice
immun
procedur
sera
prepar
accord
standard
protocol
polystyren
plate
coat
dilut
mgml
protein
nativ
hrc
peptid
figur
use
mm
carbon
ph
overnight
heptad
repeat
region
construct
nativ
hrc
sequenc
residu
remov
coat
solut
wash
thrice
pb
well
block
bsa
pb
h
sera
dilut
bsa
pb
ad
well
incub
h
sampl
solut
remov
wash
thrice
pb
tween
next
horseradish
peroxidas
conjug
igg
goat
dilut
ad
well
incub
h
sampl
solut
remov
well
wash
thrice
pb
tween
acid
mm
citrat
ph
ad
well
plate
read
nm
neutral
activ
hrc
nanoparticl
antisera
infect
vero
cell
assess
neutral
assay
perform
triplic
well
plate
biosafeti
level
laboratori
one
hundr
microlit
sera
contain
antibodi
buffer
alon
mix
sar
viru
contain
plagu
form
unit
dulbecco
modifi
eagl
medium
dmem
gibco
invitrogen
carlsbad
ca
usa
contain
fb
penicillin
streptomycin
fungizon
psf
gibco
invitrogen
deep
dish
plate
viru
incub
sera
h
serial
dilut
viru
sera
mixtur
made
dmem
fb
psf
inocul
onto
vero
cell
plate
incub
h
inocula
remov
cell
overlaid
ml
seakem
agar
contain
mem
gibco
invitrogen
fb
psf
plate
incub
h
cell
fix
stain
crystal
violet
h
plagu
count
inhibit
viral
infect
antibodi
nanoparticl
alon
nanoparticl
shown
percentag
titer
viru
incub
buffer
alon
protein
shell
virus
built
mani
copi
one
polypeptid
chain
particular
protein
shell
mani
spheric
virus
icosahedr
symmetri
attempt
mimic
natur
design
small
viru
capsid
raman
et
al
design
singl
monomer
peptid
build
block
predict
form
icosahedr
peptid
nanoparticl
idea
behind
design
build
block
symmetri
element
found
icosahedron
fivefold
threefold
twofold
rotat
symmetri
axe
also
found
use
peptid
oligomer
domain
respect
symmetri
possibl
design
build
block
would
form
peptid
nanoparticl
icosahedr
symmetri
figur
therefor
base
design
raman
et
al
monomer
build
block
peptid
nanoparticl
consist
sequenc
form
trimer
pentamer
shown
sequenc
figur
monomer
peptid
compos
pentamer
domain
short
linker
trimer
domain
extend
sar
epitop
sequenc
epitop
shown
elicit
humor
immun
respons
character
neutral
antibodi
moreov
epitop
ideal
suit
extend
de
novo
trimer
epitop
trimer
stepwis
dialysi
monom
peptid
nanoparticl
may
accommod
peptid
chain
case
icosahedron
figur
top
bigger
assembl
icosahedron
peptid
chain
figur
bottom
also
state
intermedi
number
peptid
chain
may
possibl
howev
nanoparticl
regular
icosahedr
symmetri
fact
larger
assembl
probabl
exact
icosahedr
symmetri
would
requir
pentamer
would
switch
hexam
unlik
comp
oligomer
domain
optim
interhel
contact
pentamer
trimer
sequenc
modifi
design
raman
et
al
angl
helic
constrain
disulfid
bridg
figur
experi
howev
show
peptid
nanoparticl
contain
cystein
tend
aggreg
data
shown
therefor
replac
cystein
posit
f
heptad
repeat
close
glycin
linker
alanin
shown
black
figur
modif
abrog
charact
sequenc
alanin
higher
propens
cystein
evalu
secondari
structur
effect
thermal
denatur
cd
spectroscopi
use
depict
figur
peptid
nanoparticl
show
doubl
minima
nm
characterist
structur
consist
fact
peptid
nanoparticl
compos
peptid
nanoparticl
seem
thermal
stabl
protein
unfold
figur
comput
model
predict
averag
diamet
nm
peptid
nanoparticl
icosahedr
symmetri
figur
top
similar
size
small
virus
particl
size
immunogen
import
directli
affect
immunogen
studi
use
antigen
coval
coupl
inert
differ
size
smaller
particl
nm
shown
elicit
potent
combin
cellular
humor
respons
larger
particl
transmiss
electron
microscopi
tem
reveal
peptid
chain
nanoparticl
spheric
shape
size
rang
nm
figur
compar
valu
predict
comput
model
nonetheless
peptid
nanoparticl
perfectli
spheric
shape
might
complet
regular
presenc
amino
acid
peptid
sequenc
form
six
histidin
use
purif
figur
size
per
volum
analysi
dynam
light
scatter
figur
also
show
nanoparticl
size
compar
tem
result
figur
togeth
data
indic
satisfactori
monomer
peptid
chain
form
singl
nanoparticl
expect
size
rang
investig
sizesymmetri
relationship
analyt
ultracentrifug
analys
perform
comput
model
expect
monom
form
icosahedron
molecular
weight
obtain
sediment
veloc
experi
possibl
determin
number
monom
constitut
peptid
nanoparticl
figur
display
plot
normal
sediment
coeffici
distribut
g
distribut
peak
near
use
calcul
friction
ratio
sediment
coeffici
correspond
nanoparticl
molecular
weight
mda
peptid
chain
per
nanoparticl
base
largest
fraction
peptid
nanoparticl
seem
icosahedr
symmetri
model
shown
figur
would
impli
angl
pentam
trimer
averag
slightli
smaller
shown
symmetri
figur
case
smaller
angl
would
allow
monom
singl
nanoparticl
howev
clear
g
distribut
tail
distribut
curv
higher
valu
sampl
homogen
rather
contain
mixtur
differ
speci
agre
data
obtain
dl
tem
similarli
padilla
et
al
found
differ
size
speci
design
protein
cage
attribut
certain
degre
flexibl
polymorph
assembl
particl
anoth
use
analysi
character
size
distribut
mixtur
macromolecul
sediment
veloc
run
analyt
ultracentrifug
continu
distribut
molecular
mass
c
c
plot
sampl
highest
concentr
shown
figur
molecular
mass
rang
hundr
thousand
dalton
mda
major
particl
molecular
mass
mda
correspond
averag
peptid
chain
per
particl
evalu
specif
antibodi
elicit
immun
nanoparticl
nanoparticl
qualit
elisa
perform
initi
control
experi
elisa
plate
coat
nanoparticl
without
epitop
see
whether
antibodi
recogn
nanoparticl
core
antisera
bound
strongli
nanoparticl
expect
dilut
rang
figur
logic
sequenc
control
experi
coat
elisa
plate
peptid
nanoparticl
carri
epitop
expect
antibodi
show
strong
recognit
peptid
nanoparticl
epitop
figur
dilut
rang
term
oligomer
state
hrc
peptid
present
monom
trimer
nativ
conform
want
examin
whether
antibodi
obtain
immun
would
bind
form
hrc
specif
either
monomer
trimer
state
therefor
verifi
recognit
nativ
hrc
elisa
plate
coat
sar
protein
hrc
sequenc
form
weakli
stabl
trimer
coil
coil
seen
figur
antisera
dilut
rang
bind
peptid
nativ
form
within
protein
show
strong
immunogen
natur
peptid
nanoparticl
investig
specif
trimer
conform
hrc
construct
forc
hrc
trimer
state
use
coat
elisa
plate
protein
use
express
tag
purif
tag
modifi
sequenc
maintain
construct
trimer
also
stabil
hrc
sequenc
figur
trimer
dilut
rang
antisera
bound
plate
trimer
construct
figur
hand
plate
coat
synthet
hrc
peptid
figur
form
unfold
monom
bound
elisa
plate
littl
bind
figur
result
trimer
hrc
figur
monomer
hrc
figur
indic
antibodi
produc
expect
nanoparticl
design
confirm
optim
platform
display
epitop
particular
conform
similarli
previou
experi
antigen
sequenc
found
elicit
antibodi
trimer
state
hrc
abl
bind
bundl
state
peptid
nanoparticl
design
way
de
novo
trimer
extend
trimer
stabil
trimer
epitop
howev
differ
antibodi
reactiv
like
reflect
fact
consider
fraction
antibodi
direct
core
nanoparticl
also
surfac
access
substanti
degre
anoth
reason
could
trimer
peptid
nanoparticl
contain
free
group
exist
nativ
hrc
peptid
previous
shown
ionic
interact
cooh
terminu
protein
import
interact
thu
antibodi
made
carboxyl
termini
would
necessarili
recogn
nativ
hrc
peptid
determin
elisa
sera
recogn
prefus
state
protein
test
neutral
activ
sera
mice
number
immun
sar
nanoparticl
combin
concentr
four
sera
strong
bind
activ
trimer
construct
prefus
state
protein
sera
mice
immun
nanoparticl
alon
similarli
concentr
undilut
concentr
sera
test
abil
neutral
viru
infect
result
shown
figur
sera
mice
immun
nanoparticl
show
neutral
infect
sera
mice
immun
nanoparticl
alon
signific
neutral
activ
conclus
gener
desir
antibodi
abl
neutral
infect
use
nanoparticl
present
system
futur
experi
test
conform
specif
plan
introduc
glycin
prolin
linker
de
novo
trimer
epitop
disrupt
heptad
repeat
two
sequenc
design
would
expect
observ
loss
conform
specif
immun
respons
weaker
trimer
hrc
epitop
also
engin
epitop
padr
peptid
sequenc
test
influenc
known
epitop
immunogen
nanoparticl
construct
promis
result
obtain
next
step
includ
challeng
mice
viru
test
whether
anim
recov
infect
present
platform
novel
sar
subunit
vaccin
advantag
vaccin
lack
infect
eas
protein
express
purif
high
puriti
stabil
furthermor
antibodi
sar
spike
protein
recogn
prefus
trimer
conform
hrc
neutral
activ
antibodi
obtain
without
adjuv
immunogen
effect
system
nanomet
size
particl
repetit
display
epitop
good
mimicri
epitop
nativ
conform
thu
polypeptid
nanoparticl
great
potenti
employ
vaccin
versatil
system
good
humor
immun
respons
obtain
